首页|硫酸镁联合硝苯地平对妊娠期高血压病的疗效及对动脉血流指标和母婴结局的影响

硫酸镁联合硝苯地平对妊娠期高血压病的疗效及对动脉血流指标和母婴结局的影响

扫码查看
目的 探讨硫酸镁联合硝苯地平在妊娠期高血压患者中的应用情况,并分析对动脉血流指标、母婴结局的影响。方法 回顾性选取2019年8月至2022年3月在岱山县第一人民医院治疗的妊娠期高血压患者(128例)为研究对象,按照治疗方法将患者分为观察组(64例)、对照组(64例),2组均给予常规治疗,对照组在常规治疗基础上静脉滴注硫酸镁,观察组在对照组基础上联合硝苯地平控释片治疗,比较2种不同治疗方式对患者动脉血流及母婴结局的影响。结果 2组疗效差异有统计学意义(93。8%和79。7%,P<0。05);治疗后观察组收缩压(SBP)、舒张压(DBP)、血肌酐(Scr)、血尿素氮(BUN)、尿酸(UA)、基质金属蛋白酶9(MMP9)、内皮素-1(ET-1)、搏动指数(PI)、阻力指数(RI)、动脉收缩期峰值流速(PSV)、24h尿蛋白定量、尿激肽原1、尿钙黏蛋白均低于对照组(P<0。05);但一氧化氮(NO)高于对照组(P<0。05);2组新生儿情况比较差异无统计学意义(P>0。05),观察组不良妊娠结局发生率低于对照组(P<0。05)。结论 硫酸镁联合硝苯地平可有效控制妊娠期高血压患者血压水平,并改善患者子宫动脉血流、血管内皮功能,降低肾损伤,减少不良妊娠发生率。
Therapeutic effect of magnesium sulfate combined with nifedipine on patients with pregnancy induced hy-pertension and its influence on arterial blood flow indexes and maternal and infant outcomes
Objective To investigate the combined application of magnesium sulfate and nifedipine in patients with pregnancy induced hypertension,and analyze the influence on arterial blood flow indexes and maternal and infant outcomes.Methods A retrospective study was conducted.A total of 128 patients with pregnancy induced hypertension treated in the hospital from August 2019 to March 2022 were selected as the study subjects.They were divided into the observation group(n=64)and the control group(n=64)according to different treatment methods.All patients underwent conventional treatment.On this basis,the control group was intravenously infused with magnesium sulfate.Based on the treatment of the control group,the observation group was treated with nifedipine controlled-release tablets.Arterial blood flow and maternal and infant outcomes were compared between the two groups.Results Therapeutic effects in the two groups were significantly different(93.8%vs 79.7%)(P<0.05).After treatment,systolic blood pressure(SBP),diastolic blood pressure(DBP),serum creatinine(Scr),blood urea nitrogen(BUN),uric acid(UA),matrix metalloproteinase 9(MMP9),endothelin-1(ET-1),pulsatility index(PI),resistance index(RI),peak systolic velocity(PSV),24 h urine protein quantity,urinary kininogen-1,and urine cadherin in the observation group were all lower than those in the control group(P<0.05).The level of nitric oxide(NO)was higher than that in the control group(P<0.05).Neonates of the two groups were in similar condition(P<0.05).The incidence of adverse pregnancy outcomes in the observation group was significantly lower than that in the control group(P<0.05).Conclusion The combination of magnesium sulfate and nifedipine can effectively control the blood pressure level of patients with pregnancy induced hypertension,improve patients'uterine artery blood flow and vascular endothelial function,reduce kidney damage,and lower the incidence of adverse pregnancy.

Magnesium sulfateNifedipineHypertension,pregnancy-inducedPregnancy outcome

刘维娜、周珊娜、刘丽莉

展开 >

岱山县第一人民医院妇产科,浙江舟山 316261

舟山医院产科,浙江舟山 316000

舟山市妇女儿童医院产科,浙江舟山 316200

硫酸镁 硝苯地平 高血压,妊娠性 妊娠结局

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(8)